Endometriosis

New England CEPAC

ICER will review elagolix (AbbVie) for management of endometriosis with associated pain.

Associated Meetings

July 12, 2018 9am - 5pm ET

Champlain College
Communication & Creative Media (CCM) Building
375 Maple Street
Burlington, VT 05401

The New England CEPAC will review ICER's report on elagolix for endometriosis.


Key Dates

Associated Materials

12/14/2017 – 01/08/2018

01/11/2018

01/11/2018 – 02/01/2018

01/11/2018

02/09/2018

03/16/2018

03/16/2018

05/04/2018

Open to public comment until 5pm ET on May 31, 2018. For more information on submitting a public comment, please visit our stakeholder engagement page.